当前位置:首页 - 行情中心 - 海特生物(300683) - 财务分析 - 现金流量表

海特生物

(300683)

  

流通市值:29.14亿  总市值:31.22亿
流通股本:1.22亿   总股本:1.31亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金350,718,604.64234,374,737.41113,179,980.17503,810,380.48
  收到的税费返还67,140.1867,140.1850,436.21139,833.2
  收到其他与经营活动有关的现金17,217,478.7613,749,169.5612,024,503.1127,292,446.3
  经营活动现金流入小计368,003,223.58248,191,047.15125,254,919.49531,242,659.98
  购买商品、接受劳务支付的现金119,825,126.3979,577,590.5839,149,683.02167,070,193.01
  支付给职工以及为职工支付的现金134,320,484.6694,770,962.6351,931,007.84241,653,525.31
  支付的各项税费23,568,246.0417,123,853.697,483,458.2423,619,536.39
  支付其他与经营活动有关的现金96,447,449.5559,593,350.4429,202,743.57175,437,382.05
  经营活动现金流出小计374,161,306.64251,065,757.34127,766,892.67607,780,636.76
  经营活动产生的现金流量净额-6,158,083.06-2,874,710.19-2,511,973.18-76,537,976.78
二、投资活动产生的现金流量:
  收回投资收到的现金585,515,903.57416,715,903.57278,115,903.571,635,396,794.52
  取得投资收益收到的现金2,701,422.021,891,986.51,584,382.112,848,345.09
  处置固定资产、无形资产和其他长期资产收回的现金净额1,066,813.67564,385.71483,7001,369,673.51
  投资活动现金流入小计589,284,139.26419,172,275.78280,183,985.671,649,614,813.12
  购建固定资产、无形资产和其他长期资产支付的现金23,952,081.519,609,071.5511,928,736.7150,535,918.57
  投资支付的现金1,042,493,589.87840,693,589.87646,503,455.51,265,187,978.38
  支付其他与投资活动有关的现金179,397.27--971,643.5
  投资活动现金流出小计1,066,625,068.64860,302,661.42658,432,192.211,316,695,540.45
  投资活动产生的现金流量净额-477,340,929.38-441,130,385.64-378,248,206.54332,919,272.67
三、筹资活动产生的现金流量:
  吸收投资收到的现金---4,000,000
  其中:子公司吸收少数股东投资收到的现金---4,000,000
  筹资活动现金流入平衡项目---0
  筹资活动现金流入小计---4,000,000
  偿还债务支付的现金19,737,204.7163,658.371,003,139.424,964,789.88
  分配股利、利润或偿付利息支付的现金2,058,934.921,948,732.65-17,869,627.71
  支付其他与筹资活动有关的现金4,517,715.844,348,431.044,170,431.048,421,505
  筹资活动现金流出小计26,313,855.466,460,822.065,173,570.4631,255,922.59
  筹资活动产生的现金流量净额-26,313,855.46-6,460,822.06-5,173,570.46-27,255,922.59
四、汇率变动对现金及现金等价物的影响-28,439.35-26,073.92-14,826.84-3,164.26
五、现金及现金等价物净增加额-509,841,307.25-450,491,991.81-385,948,577.02229,122,209.04
  加:期初现金及现金等价物余额648,242,569.6648,242,569.6648,242,569.6419,120,360.56
  期末现金及现金等价物余额138,401,262.35197,750,577.79262,293,992.58648,242,569.6
补充资料:
  净利润--79,888,350.24--235,430,201.19
  资产减值准备-4,764,842.38-124,202,306.5
  固定资产和投资性房地产折旧-31,293,256.59-68,204,958.96
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-31,293,256.59-68,204,958.96
  无形资产摊销-12,397,046.46-25,565,530
  长期待摊费用摊销-718,077.82-2,490,095.9
  处置固定资产、无形资产和其他长期资产的损失-2,301,165.53-979,179.5
  固定资产报废损失-513,979.84-233,444.38
  公允价值变动损失--1,108,216.31-12,521,343.58
  财务费用-525,151.83-1,390,342.84
  投资损失-1,865,475.3--20,643,544.25
  递延所得税--7,411,986.58--3,965,614.84
  其中:递延所得税资产减少--6,519,738.26--582,897.47
    递延所得税负债增加--892,248.32--3,382,717.37
  存货的减少--2,116,241.43-12,378,341.24
  经营性应收项目的减少-1,224,963.08--8,709,997.93
  经营性应付项目的增加-31,490,283.11--59,329,889.96
  现金的期末余额-197,750,577.79-648,242,569.6
  减:现金的期初余额-648,242,569.6-419,120,360.56
  现金及现金等价物的净增加额--450,491,991.81-229,122,209.04
公告日期2026-10-232026-08-242026-04-242026-04-24
审计意见(境内)标准无保留意见
TOP↑